Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane is a vital phospholipid bilayer that functions as a selective permeability barrier and a platform for essential biological processes, including energy production, nutrient transport, and cell wall assembly (Source: NIH, StatPearls). It consists of the cytoplasmic (inner) membrane in all bacteria and an additional outer membrane in Gram-negative species, which contains lipopolysaccharides and porins that regulate drug entry (Source: Wikipedia, 2024). Membrane proteins, such as penicillin-binding proteins (PBPs) and various transporters, are critical for maintaining cellular homeostasis and structural integrity (Source: UniProt). This target is the site of action for several major antibiotic classes; for example, polymyxins target the outer membrane of Gram-negative bacteria, while lipopeptides like daptomycin disrupt the inner membrane of Gram-positive bacteria (Source: PubMed, 2023). Because bacterial membranes contain unique lipids like phosphatidylglycerol that are less prevalent in mammalian cells, they offer a basis for selective toxicity, though clinical use can be limited by side effects such as nephrotoxicity and neurotoxicity (Source: PubChem).
Drugs targeting the bacterial membrane typically act through membrane disruption, pore formation, or the inhibition of membrane-bound enzymes. Polymyxins bind to lipopolysaccharides and phospholipids in the outer membrane of Gram-negative bacteria, leading to increased permeability and cell death. Daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria in a calcium-dependent manner, causing rapid depolarization and cessation of DNA, RNA, and protein synthesis. Other agents, like beta-lactams, inhibit membrane-anchored penicillin-binding proteins (PBPs) to disrupt cell wall synthesis (Source: StatPearls, PubMed).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and membrane proteins.